Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JB-101 in Living Donor Liver Transplantation
NCT04950842Phase 2Active, not recruiting
- Sponsor
- Juntendo University
- Start
- Dec 2020
- Primary completion
- Feb 2026
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of JB-101 in Liver transplant rejection, sponsored by Juntendo University. Started Dec 2020; status: active, not recruiting.
02
Drugs
JB-101
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04950842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04950842.